Walleye Capital
AMAG

Walleye Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Walleye Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$1K – 1127
2020
Q1 		$1K Buy
+100
New +$881 ﹤0.01% 833
2019
Q4 		– Sell
-9,300
Closed -$107K – 2435
2019
Q3 		$107K Buy
9,300
+5,000
+116% +$52.6K 0.01% 1416
2019
Q2 		$43K Sell
4,300
-5,400
-56% -$58.3K ﹤0.01% 1413
2019
Q1 		$125K Buy
+9,700
New +$144K 0.02% 964
2018
Q3 		$374K Buy
+18,700
New +$426K 0.17% 153

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Walleye Capital's AMAG Position: Q2 2020 in Review

Walleye Capital sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 34,609 shares — an estimated $214K sold.

Walleye Capital first reported a position in AMAG in Q1 2020 and held it in 1 quarter. The position peaked at $214K in Q1 2020. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Walleye Capital reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Walleye Capital sold 34,609 AMAG Pharmaceuticals shares in Q2 2020, an estimated $214K.
  • Walleye Capital first reported a position in AMAG Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Walleye Capital's AMAG Pharmaceuticals position peaked at $214K in Q1 2020.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Walleye Capital's 13F filing for Q2 2020, filed 14 Aug 2020.